Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
700 participants
OBSERVATIONAL
2020-02-01
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities
NCT00716235
To Explore the Neural Processing Mechanism of Cerebellum Involved in Facial Expression Recognition Based on Transcranial Magnetic Stimulation
NCT06860451
Studying Eye Movement Deficits and Cognitive Impairment in Patients with Multiple Sclerosis Using Infrared Eye Tracking and Cognitive Tests
NCT06629155
Mirroring a Movement
NCT00123448
Study of Epidemiologic Investigation and Mechanism of Brain Network of Otologic and Cognitive Function With Post-COVID-19
NCT05787301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal
Subjects over 45 years old without cognitive dysfunction
No interventions assigned to this group
Mild cognitive decline
Subjects who are diagnosed as mild cognitive decline(MCI) according to neurologists.
No interventions assigned to this group
Alzheimer's disease
Subjects who are diagnosed as Alzheimer's disease(AD) according to neurologists.
No interventions assigned to this group
Vascular dementia
Subjects who are diagnosed as vascular dementia(VD) according to neurologists.
No interventions assigned to this group
Lewy body dementia
Subjects who are diagnosed as Lewy body demenita (DLB) according to neurologists.
No interventions assigned to this group
Frontotemporal dementia
Subjects who are diagnosed as Frontotemporal demenita (FD) according to neurologists.
No interventions assigned to this group
Other dementia
Subjects who are diagnosed as dementia but are not as AD, VD, DLB OR FD.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ②Subjects who can cooperate with the inspection.
* ③Subjects who agree to participate in the study and sign the consent form
Exclusion Criteria
* ②Subjects who suffer from diseases that compromise the inspection.
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haotian Lin
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haotian Lin, M.D.,Ph.D
Role: STUDY_CHAIR
Zhongshan Ophthalmic Center, Sun Yat-sen University
Xun Wang, M.D.,Ph.D
Role: STUDY_DIRECTOR
Zhongshan Ophthalmic Center, Sun Yat-sen University
Shuyi Zhang, M.D.
Role: PRINCIPAL_INVESTIGATOR
Zhongshan Ophthalmic Center, Sun Yat-sen University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Eye movement-cognitive decline
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.